Wells Fargo Maintains Equal-Weight on GoodRx Holdings, Raises Price Target to $7.5
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Stan Berenshteyn maintains an Equal-Weight rating on GoodRx Holdings (GDRX) and raises the price target from $6 to $7.5.
March 01, 2024 | 6:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wells Fargo maintains an Equal-Weight rating on GoodRx Holdings and raises the price target to $7.5 from $6.
The increase in price target by Wells Fargo suggests a positive outlook on GoodRx Holdings' stock, potentially leading to short-term price appreciation. The maintenance of an Equal-Weight rating indicates a neutral long-term view, but the raised target is a bullish signal for short-term investors.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100